Product Liability

Toyota Re-recalls 766,300 Vehicles for Airbag Shrapnel

Toyota to recall hundreds of thousands of vehicles for shrapnel risk from airbagsToyota is recalling 766,300 cars and trucks in the United States for continued risk of shrapnel from passenger-side airbags. Toyota recalled vehicles in April 2013 for the same issue, but has discovered that the supplier, the Takata Corporation, may not have provided a comprehensive list of all of the cars that were potentially affected.

These recalls are because of improper manufacturing of Takata ...

continue reading...

CPSC Recalls Residential Elevators after Boy Suffers Catastrophic Brain Injury

The U.S. Consumer Product Safety Commission (CPSC) is recalling residential elevator units after three reports of incidents, one of which left a 10-year-old boy with a catastrophic brain injury. The elevators in question are Elmira Hydraulic residential elevators, manufactured by Cambridge Elevating and distributed by Coastal Carolina Elevators.

Elmira Hydraulic units were installed in homes with multiple floors. According to the CPSC’s description, “they have a manual accordion-style car gate door with vinyl laminate inserts and a control panel ...

continue reading...

With Power Morcellation Under Scrutiny, What Are the Other Options?

Power morcellation was, until recently, considered a reasonable option for women seeking treatment for uterine fibroids. Amidst FDA warnings and various recalls, this option has been largely advised against. An article in the Wall Street Journal discusses the alternatives to power morcellation that are available to women that want to avoid this risky procedure.

Laparoscopic power morcellators are currently being investigated regarding their potential risk in spreading cancerous tumors in women. The device is ...

continue reading...

Takeda Pharmaceuticals Accused of Neglecting Patient Safety in Actos Marketing

Unfortunately, pharmaceutical companies sometimes put profits ahead of all else. While it seems that patient safety should be at the forefront of a company’s efforts in drug development, some actions can raise questions as to a company’s true priorities. A recent Bloomberg article details the Philadelphia trial of a woman who claims the company marketed its diabetes drug Actos with little regard to patient safety. The plaintiff, who has developed cancer, claimed that the company failed to sufficiently ...

continue reading...

New Jersey Jury Awards $1.58 Million in Accutane Trial Verdict

In the case Rees v. Hoffman-LaRoche, Inc., a New Jersey jury awarded the plaintiff $1,587,928 in what is the ninth straight Accutane trial verdict in favor of plaintiffs. The jury found that the drug could cause ulcerative colitis and that Hoffman-La Roche, its manufacturer, failed to adequately warn of this risk. Trial ran from January 27 to March 10, and the jury rendered its verdict in less than a day.

Accutane was a drug for treatment of ...

continue reading...

GM Emails Suggest Cost a Factor in Faulty Ignition Switch

The New York Times reported today that emails released during ongoing congressional hearings about GM’s faulty ignition switches discussed the cost of fixing the switch.

Based on the emails, which were written in 2005, it appears that the cost of the fixing the switch was a factor in why a change was delayed for years. Several people died in accidents caused by ignition switch failures. Because power to ...

continue reading...
Page 1 of 131 12345...»